We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-18.19%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$13.6B
AUM Growth
+$1.76B
(+15%)
Cap. Flow
+$4.28B
Cap. Flow
% of AUM
31.58%
Top 10 Holdings %
Top 10 Hldgs %
12.23%
Holding
3,376
New
988
Increased
735
Reduced
602
Closed
941
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$170M |
| 2 |
Marathon Petroleum
MPC
|
+$162M |
| 3 |
Microsoft
MSFT
|
+$149M |
| 4 |
Chevron
CVX
|
+$147M |
| 5 |
Meta Platforms (Facebook)
META
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$100M |
| 2 |
Zoetis
ZTS
|
+$78.9M |
| 3 |
CERN
Cerner Corp
CERN
|
+$74M |
| 4 |
Sun Communities
SUI
|
+$68.8M |
| 5 |
Mondelez International
MDLZ
|
+$68.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.59% |
| 2 | Financials | 11.55% |
| 3 | Healthcare | 11.46% |
| 4 | Energy | 9.75% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Harrow
HROW
$1.4B
| $107K | ﹤0.01% |
+14,647
| New | +$98.8K |
|
|
MRSN
1927
DELISTED
Mersana Therapeutics
MRSN
| $107K | ﹤0.01% |
925
-11,053
| -92% | -$1.04M |
|
1928
Scholar Rock
SRRK
$5.86B
| $107K | ﹤0.01% |
19,571
-9,104
| -32% | -$65.4K |
|
1929
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $106K | ﹤0.01% |
2,454
+2,321
| +1,745% | +$105K |
|
1930
First Trust Nasdaq Oil & Gas ETF
FTXN
$162M
| $106K | ﹤0.01% |
+4,546
| New | +$124K |
|
1931
SEACOR Marine Holdings
SMHI
$219M
| $106K | ﹤0.01% |
+18,363
| New | +$145K |
|
1932
Verastem
VSTM
$534M
| $106K | ﹤0.01% |
+7,633
| New | +$122K |
|
1933
Acumen Pharmaceuticals
ABOS
$159M
| $105K | ﹤0.01% |
+22,259
| New | +$83.6K |
|
1934
iShares US Energy ETF
IYE
$1.71B
| $105K | ﹤0.01% |
2,766
+2,427
| +716% | +$103K |
|
1935
Lantronix
LTRX
$244M
| $105K | ﹤0.01% |
19,454
+3,975
| +26% | +$22.9K |
|
1936
Avita Medical
RCEL
$146M
| $105K | ﹤0.01% |
+22,053
| New | +$136K |
|
|
AKUS
1937
DELISTED
Akouos Inc
AKUS
| $105K | ﹤0.01% |
+22,328
| New | +$78.9K |
|
1938
Acco Brands
ACCO
$381M
| $104K | ﹤0.01% |
15,901
-65,301
| -80% | -$476K |
|
1939
iShares US Financials ETF
IYF
$4.68B
| $104K | ﹤0.01% |
1,489
-1,197
| -45% | -$91.3K |
|
1940
ProShares Ultra Russell2000
UWM
$248M
| $104K | ﹤0.01% |
3,369
+1,644
| +95% | +$61.1K |
|
1941
Fidelity MSCI Information Technology Index ETF
FTEC
$19.7B
| $103K | ﹤0.01% |
1,066
+722
| +210% | +$76.9K |
|
1942
Amplify Online Retail ETF
IBUY
$110M
| $103K | ﹤0.01% |
2,450
-2,303
| -48% | -$118K |
|
1943
Olema Pharmaceuticals
OLMA
$1.05B
| $103K | ﹤0.01% |
+25,315
| New | +$80.3K |
|
1944
CytomX Therapeutics
CTMX
$708M
| $102K | ﹤0.01% |
+55,846
| New | +$107K |
|
|
IVAC
1945
DELISTED
Intevac Inc
IVAC
| $102K | ﹤0.01% |
+21,172
| New | +$108K |
|
|
ADVM
1946
DELISTED
Adverum Biotechnologies
ADVM
| $101K | ﹤0.01% |
+8,389
| New | +$87.9K |
|
1947
AquaBounty Technologies
AQB
$4.63M
| $101K | ﹤0.01% |
+2,957
| New | +$90.3K |
|
1948
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$233M
| $101K | ﹤0.01% |
3,292
-5,364
| -62% | -$239K |
|
1949
Sprott Physical Silver Trust
PSLV
$12B
| $101K | ﹤0.01% |
14,625
| – | – |
|
1950
ProShares UltraPro Dow 30
UDOW
$830M
| $101K | ﹤0.01% |
4,116
-65,804
| -94% | -$1.98M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q2 2022 Portfolio in Review
As of Q2 2022, Qube Research & Technologies (QRT) held 3,376 positions worth $13.6B, up 15% from $11.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.28B of net new capital in Q2 2022, opening 988 new positions and adding to 735 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 541,117 shares worth $148M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Verizon, an estimated $100M trimmed.
- Qube Research & Technologies (QRT)'s largest Q2 2022 buy was Berkshire Hathaway Class B: 541,117 shares worth $148M.
- Qube Research & Technologies (QRT) added most to Marathon Petroleum in Q2 2022, an estimated $162M increase.
- Qube Research & Technologies (QRT)'s biggest Q2 2022 reduction was Verizon, cutting an estimated $100M.
- Qube Research & Technologies (QRT) fully exited Cerner Corp in Q2 2022, selling an estimated $74M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 12% of its $13.6B portfolio in Q2 2022.
- Qube Research & Technologies (QRT) opened 988 new positions and closed 941 in Q2 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 15% quarter-over-quarter to $13.6B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.